The Plaintiff against Xarelto Manufacturers. Several pharmaceutical companies are being sued by an estate executor who alleges an anticoagulant drug was the cause of his mother’s death. On May 25, 2016, in the U.S. District Court for the Eastern District of Louisiana, a complaint was filed against Janssen Research & Development LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., and Bayer Healthcare Pharmaceuticals Inc., the makers of Xarelto, the blood-thinning medicationin question. The lawsuit is alleging strict liability, manufacturing defect and other counts, The Louisiana Record reports.
Xarelto was taken by the plaintiff’s mother from approximately June 30, 2014 to July 6, 2014. She experienced severe internal bleeding and ultimately died on July 6, 2014. The plaintiff holds the manufacturers responsible for a variety of reasons including: failure to properly investigate, research, and define the safety of the drug; failure to provide adequate warnings; failure to disclose the need for dose adjustments; failure to provide adequate instructions on the drug’s use, according to The Louisiana Record.
The established anticoagulants like Coumadin (warfarin) require stringent, regular blood testing and a strict diet regimen whereas, the newer blood-thinning medicines such as Xarelto are more convenient with no regular blood monitoring and no specific dietary restrictions.
Xarelto was prescribed for knee or hip replacements and for deep vein thrombosis (blood clots in the veins of the legs). This medication was meant to prevent blood clots from forming and to keep blood flowing smoothly. However, they may leave patients open to serious injury or even death, according to WebMD.
The plaintiff in the Louisiana case requests a trial by jury and seeks compensatory damages in excess of the judiciary amount, reports The Louisiana Record.